Truist Financial increased its price objective for Concentra, with MarketBeat aggregating the stock ratings.
5 reports, 1 independent
Updated Sep 10
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial increased its price objective for Concentra, with MarketBeat aggregating the stock ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Concentra
US health care company
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
MarketBeat
American personal finance blog
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- MarketBeat aggregated analyst ratings on ENI stock on August 31, 2026.
- MarketBeat reported an average stock rating for Superior Group of Companies.
- BTG Pactual provided a target price and research report for Logistic Properties of the Americas, which was aggregated by MarketBeat.